Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 7, Issue 3, pp. 401-413
PubMed
Published By
Print ISSN
Online ISSN
History
- Received August 10, 2018
- Revision received November 2, 2018
- Accepted January 22, 2019
- Published first January 25, 2019.
Article Versions
- Previous version (January 25, 2019 - 07:18).
- Previous version (February 15, 2019 - 06:40).
- You are viewing the most recent version of this article.
Copyright & Usage
©2019 American Association for Cancer Research.
Author Information
- Tadanobu Nagaya1,
- Jay Friedman2,
- Yasuhiro Maruoka1,
- Fusa Ogata1,
- Shuhei Okuyama1,
- Paul E. Clavijo2,
- Peter L. Choyke1,
- Clint Allen2,*, and
- Hisataka Kobayashi1,*
- 1Molecular Imaging Program, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
- 2Translational Tumor Immunology Program, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland.
- ↵*Corresponding Authors:
Hisataka Kobayashi, NCI, Building 10, Room B3B69, MSC 1088, 10 Center Drive, Bethesda, MD 20892-1088. Phone: 301-435-4086; Fax: 301-402-3191; E-mail: kobayash{at}mail.nih.gov; and Clint Allen, E-mail: clint.allen{at}nih.gov
March 2019
Volume 7, Issue 3
Volume 7, Issue 3
Host Immunity Following Near-Infrared Photoimmunotherapy Is Enhanced with PD-1 Checkpoint Blockade to Eradicate Established Antigenic Tumors
Jump to section
Advertisement